Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice.
Neuropathol Appl Neurobiol
; 47(7): 1004-1018, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-33508894
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Lysophosphatidic Acid
/
Superoxide Dismutase-1
/
Amyotrophic Lateral Sclerosis
/
Motor Neurons
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Neuropathol Appl Neurobiol
Year:
2021
Document type:
Article
Affiliation country:
España
Country of publication:
Reino Unido